The influence of p53 in immunity is an extensive topic (reviewed in Agupitan et al., 2020) with evident sex-disparity [as we identified in non-small cell lung cancers to be linked to TP53 status and sex (Freudenstein et al., 2020)]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.